Ralf Kunzmann

Austria Wirtschaftsservice GmbH (AWS) is the Austrian promotional bank, fully controlled by the Government of Austria. Based in Vienna, AWS emerged in 2002 from the merger of several government funding agencies including FGG-Finanzierungsgarantiegesellschaft mbH and BÜRGES Förderungsbank GmbH. The firm later absorbed Innovationsagentur GmbH. The Seed Financing division of AWS manages venture capital investments by way of mezzanine financing. AWS also comprises several divisions not directly involved in investment management, namely Tecma which is specialized in technology marketing support, Tecnet which supplies technology information, i²-Ideas & Investment which is a networking platform for business angels and Biotech, providing business support for biotechnology projects. AWS manages the university spin-off fund Uni Venture, sponsored by BAWAG-Bank für Arbeit und Wirtschaft.

aws-mittelstandsfonds Management GmbH provides investment services. It offers services that allows to increase production and marketing capacity and invest in new technologies. The company is headquartered in Vienna, Austria.

BA Private Equity GmbH (formerly BA-CA Private Equity) is the private equity arm and a wholly-owned subsidiary of Bank Austria Creditanstalt AG (BA-CA), a leading Austrian banking group. BA-CA is a majority-owned subsidiary of UniCredit SpA (MI: UCG). BA-PE was established in 2001 and is located in Vienna. The firm regroups three specialized groups, who manage a venture capital fund, a private equity funds and a mezzanine fund. BA-PE contributes to BA-CA's ICF-Integrated Corporate Finance capabilities. The firm's investors include the parent bank BA-CA as well as German and international institutions.

Miracor Medical SA engages in the development and manufacture of medical devices. Its product PICSO (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System has a driving console and associated catheters to improve outcomes for severe heart attack patients. It seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack. The company was founded by Werner Mohl in May, 2008 and is headquartered in Vienna, Austria.